BiotechTube
Home/IntraBio/Taylor Fields
TF

Taylor Fields

Chief Development Officer & President, Product Development

IntraBio

Therapeutic Areas

Neurodegenerative DiseasesLysosomal Storage Diseases

IntraBio Pipeline

DrugIndicationPhase
IB1001 (N-acetyl-L-leucine)Niemann-Pick disease type C (NPC)Phase 3
AQNEURSA™ (levacetylleucine)Not specified in provided dataApproved

Leadership Team at IntraBio

PM
Prof. Mallory Factor
Chairman & Chief Executive Officer
DM
Dr. Marc C. Patterson
US Chief Medical Officer
PA
Prof. Antony Galione FRS FMedSci
Founding Scientist
PF
Prof. Frances Platt FRS FMedSci
Founding Scientist
View full IntraBio profile